Analysis and verification of N6-methyladenosine-modified genes as novel biomarkers for clear cell renal cell carcinoma
N6-methyladenosine (m6A) has been involved in diverse biological processes in cancer, but its function and clinical value in clear cell renal cell carcinoma (ccRCC) remain largely unknown. In this study, we found that 1453 m6A-modified differentially expressed genes (DEGs) of ccRCC were mainly enric...
Guardado en:
Autores principales: | Zhenyu Yang, Bo Peng, Yongbo Pan, Yinmin Gu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8aa872fcdd8042279b26c4fa6a633749 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis
por: Yadi Zhou, et al.
Publicado: (2021) -
Diagnostic and prognostic value of placental growth factor serum concentration in clear cell renal cell carcinoma
por: Marcela Cechova, et al.
Publicado: (2021) -
Identification TRIM46 as a Potential Biomarker and Therapeutic Target for Clear Cell Renal Cell Carcinoma Through Comprehensive Bioinformatics Analyses
por: Xiang-bin Ren, et al.
Publicado: (2021) -
Microenvironment-associated gene HSD11B1 may serve as a prognostic biomarker in clear cell renal cell carcinoma: a study based on TCGA, RT‑qPCR, Western blotting, and immunohistochemistry
por: Di Han, et al.
Publicado: (2021) -
Spatio-Temporal Expression Profile of Mettl3/Mettl14 During Mouse Retina Development
por: Zhong,Qi, et al.
Publicado: (2020)